Assessing the genetic overlap between BMI and cognitive function by Marioni, R E et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessing the genetic overlap between BMI and cognitive
function
Citation for published version:
Marioni, RE, Yang, J, Dykiert, D, Mõttus, R, Campbell, A, Davies, G, Hayward, C, Porteous, DJ, Visscher,
PM, Deary, IJ & CHARGE Cognitive Working Group 2016, 'Assessing the genetic overlap between BMI and
cognitive function', Molecular Psychiatry, vol. 21, no. 10, pp. 1477-1482.
https://doi.org/10.1038/mp.2015.205
Digital Object Identifier (DOI):
10.1038/mp.2015.205
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Molecular Psychiatry
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
OPEN
ORIGINAL ARTICLE
Assessing the genetic overlap between BMI and cognitive
function
RE Marioni1,2,3, J Yang3, D Dykiert1,4, R Mõttus1,4, A Campbell5, CHARGE Cognitive Working Group8, G Davies1,4, C Hayward5,6,
DJ Porteous1,2,5, PM Visscher1,3,7 and IJ Deary1,4,5
Obesity and low cognitive function are associated with multiple adverse health outcomes across the life course. They have a small
phenotypic correlation (r=− 0.11; high body mass index (BMI)− low cognitive function), but whether they have a shared genetic
aetiology is unknown. We investigated the phenotypic and genetic correlations between the traits using data from 6815 unrelated,
genotyped members of Generation Scotland, an ethnically homogeneous cohort from five sites across Scotland. Genetic
correlations were estimated using the following: same-sample bivariate genome-wide complex trait analysis (GCTA)–GREML;
independent samples bivariate GCTA–GREML using Generation Scotland for cognitive data and four other samples (n= 20 806) for
BMI; and bivariate LDSC analysis using the largest genome-wide association study (GWAS) summary data on cognitive function
(n= 48 462) and BMI (n= 339 224) to date. The GWAS summary data were also used to create polygenic scores for the two traits,
with within- and cross-trait prediction taking place in the independent Generation Scotland cohort. A large genetic correlation
of − 0.51 (s.e. 0.15) was observed using the same-sample GCTA–GREML approach compared with − 0.10 (s.e. 0.08) from the
independent-samples GCTA–GREML approach and − 0.22 (s.e. 0.03) from the bivariate LDSC analysis. A genetic profile score using
cognition-specific genetic variants accounts for 0.08% (P= 0.020) of the variance in BMI and a genetic profile score using
BMI-specific variants accounts for 0.42% (P= 1.9 × 10− 7) of the variance in cognitive function. Seven common genetic variants are
significantly associated with both traits at Po5 × 10− 5, which is significantly more than expected by chance (P= 0.007). All these
results suggest there are shared genetic contributions to BMI and cognitive function.
Molecular Psychiatry advance online publication, 9 February 2016; doi:10.1038/mp.2015.205
INTRODUCTION
The obesity epidemic in the United Kingdom is a major public
health problem. High body mass index (BMI), a marker of obesity,
has been associated with an increased risk of multiple disease and
health outcomes, such as type 2 diabetes and cardiovascular
disease.1–3 It has also been associated with lower cognitive
function.4 Possible mechanisms of this link include brain atrophy5
and type 2 diabetes,6 although the causality of such associations is
not yet clear.7 Moreover, a recent study identified an association
between increased BMI and a lower risk of dementia.8 Studies
show genetic influences on both cognitive function9 and BMI.10
Twin models indicate inconsistent findings regarding the genetic
correlation between the traits.11–13 Some report a genetic
correlation of around 0.27 (such that genes for poorer cognitive
performance correlate associate with genes for a higher BMI),12
others a genetic correlation of 0.12,13 whereas one found a null
association.11 However, a genetic correlation has not yet been
examined at the molecular genetic level. Identification of any
shared genetic contributions could aid our understanding of the
phenotypic association between lower cognitive function and
higher BMI. This could also shed light on the aetiology of the
health outcomes with which both are associated, such as
increased mortality risk.14–17
Molecular genetic studies have shown that common genetic
variants explain around 30% of individual differences in cognitive
function9 and around 10–20% of individual differences in BMI in
adults (~30% in adolescents).18–20 However, this approach, using
genome-wide complex trait analysis (GCTA–GREML), does not
identify the specific variants and genes that contribute to the
associations. One approach that uses information from specific
genetic variants is polygenic scoring, which uses effect sizes
(or, the strength of associations of different loci with the phenotype
in question) from large genome-wide association studies (GWASs)
to build linear predictors of the phenotype in independent cohorts.
For example, previous studies have shown that a polygenic score
for cognitive function (based on a GWAS of 48 462 people) predicts
1.27% of the variance in cognitive function in an independent
cohort.9 One can also examine polygenic scores for correlated traits,
for example, a higher polygenic score for schizophrenia is
correlated with greater life-course cognitive decline.21
Here we examine the genotypic correlations between cognitive
function and BMI. The genetic correlations are calculated using
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three different approaches: (1) bivariate GCTA–GREML22,23 where
both BMI and cognitive function are measured in the same
sample; (2) bivariate GCTA–GREML wherein the traits are
measured in different samples; and (3) LDSC regression,24 which
uses summary GWAS data with potentially overlapping partici-
pants for each trait. We also relate polygenic risk scores for the
two traits—predicting both within and across traits. Finally, we
examine the overlap between existing GWAS analyses of both BMI
and cognitive function, to identify individual single-nucleotide
polymorphism (SNP) variants and genes that may be involved in
shared biological pathways.
MATERIALS AND METHODS
Data for the same-sample GCTA–GREML analysis, the phenotypic
correlation analysis and the independent cohort for the polygenic
prediction analysis came from Generation Scotland: the Scottish Family
Health Study, a population-based, family-structured cohort that sampled
over 24 000 people in Scotland between the years 2006 and 2011.25,26 The
study was set up for family-based genetic epidemiology research; health
outcomes including coronary heart disease, stroke, cancer, chronic
obstructive pulmonary disease, diabetes and mental illness are highly
prevalent in Scotland. The sampling frame of the study focused on 7953
probands between ages 35–65 years, who were registered with
participating general medical practitioners from five regional centres:
Glasgow, Tayside, Ayrshire, Arran and the North-East of Scotland. The
probands were invited to participate through the patient lists at the
participating general medical practices; in the United Kingdom, ~ 96% of
the population is registered with a general practitioner.26 Up to three
generations of the probands’ relatives were then recruited. There was no
ascertainment bias towards a particular disease or health condition. A full
description of the cohort has been given previously25,26 and at www.
generationscotland.org.
Cognitive function data for the independent-samples bivariate GCTA
genetic correlation analysis came from Generation Scotland.25,26 Open
access data from dbGaP for the Gene Environment Association Studies
initiative (GENEVA) project (comprising three studies, total n= 14 347:
Atherosclerosis Risk in the Community, Nurses’ Health Study and the
Health Professionals’ Follow-up Study) and the Health and Retirement
Study (n=8652) were used for the BMI analysis. Their dbGaP accession
numbers are phs000090.v1.p1 (Atherosclerosis Risk in the Community),
phs000091.v2.p1 (GENEVA-T2D) and phs000428.v1.p1 (Health and Retirement
Study). A summary description of the three cohorts and details about quality
controls of genotyped data and imputation can be found elsewhere.27
For the LDSC genetic correlation analysis, summary data from the largest
GWAS studies to date for cognitive function9 and BMI10 were used.
Generation Scotland ethical details
All components of Generation Scotland received ethical approval from the
Nurses’ Health Study Tayside Committee on Medical Research Ethics (REC
Reference Number: 05/S1401/89). Generation Scotland: Scottish Family
Health Study has also been granted Research Tissue Bank status by the
Tayside Committee on Medical Research Ethics (REC Reference Number:
10/S1402/20), providing generic ethical approval for a wide range of uses
within medical research.
BMI in Generation Scotland
BMI was measured as weight in kilograms divided by height in metres
squared (measurement details in Supplementary Information File S1).
Participants with a BMI o17 or > 50 were considered as outliers and were
removed before the analyses.
Cognitive function in Generation Scotland
A general cognitive factor was obtained via a principal component analysis
of four cognitive tests that measured processing speed (Wechsler Digit
Symbol Substitution Task28), verbal declarative memory (Wechsler Logical
Memory Test; sum of immediate and delayed recall of one paragraph29),
executive function (phonemic Verbal Fluency Test; using the letters C,
F and L, each for 1 min30) and vocabulary (the Mill Hill Vocabulary Scale;
junior and senior synonyms combined31). The first unrotated principal
component, which explained 42% of the variance of the four tests, was
extracted and used as the cognitive variable of interest. Three of the four
cognitive tests that were used to derive the general cognitive factor were
based on verbal stimuli (Verbal Fluency Test, Mill Hill Vocabulary Scale and
the Logical Memory Test); however, they, along with the Digit Symbol test,
targeted different domains of cognitive function: executive function,
vocabulary, memory and processing speed, respectively. The statistically
derived general cognitive factor therefore includes common variance from
these four different facets of cognitive function.
Generation Scotland genotyping
Genome-wide genotyping data were measured on a sub-sample of 10 000
participants using the Illumina HumanOmniExpressExome-8 v1.0 DNA
Analysis BeadChip and Infinium chemistry.32 Measurement details and
quality-control steps are reported in Supplementary Information File S1.
After quality control, there was an analysis sample of 6815 unrelated
individuals. SNPs with a minor allele frequency below 1% were excluded
before the analysis, to prevent rare variants having an influence on the
downstream analyses.
Generation Scotland, GENEVA and Health and Retirement Study
imputation and quality control
Genotype data in Generation Scotland, GENEVA and the health and
retirement study were imputed to either HapMap2 or 1000G. Imputation
details and quality control steps are reported in Supplementary
Information File S1. After quality control, there were 27 791 unrelated
individuals for analysis in the combined data set. Both phenotypes were
adjusted for age in each gender group in each cohort separately. As the
genotype data were imputed based on different reference panels, we
included in the analysis only the SNPs in common with the HapMap3
panel, because the HapMap3 SNP set was optimised to capture common
genetic variation in the human genome.33
Statistical analyses
All phenotypic data analyses were conducted on the unrelated Generation
Scotland cohort who had genome-wide genotyping data available
(n=6815). To determine the associations between cognitive function
and BMI, a linear model was used with general cognitive factor as the
independent variable. Age and sex were included as covariates.
Age-, sex- and population stratification-adjusted residuals for general
cognitive function and BMI were computed by linear regression. A
conservative number (fourteen) of ancestry components were included.34
The residual values were carried forward to genome-wide complex trait
analyses—GCTA-GREML22,35—to obtain the proportion of variation in the
variables explained by common SNPs. The univariate GCTA-GREML esti-
mates for general cognitive function have been reported previously.34
Three methods were used to estimate the genetic correlation between
BMI and general cognitive function. First, bivariate GCTA-GREML23 was run
in Generation Scotland where the phenotypic and genotypic information
came from the same unrelated individuals. This approach estimates the
extent to which genetic similarities correlate with phenotypic similarities.
However, the relatively small sample size (and corresponding large s.e.) for
this analysis resulted in an imprecise estimate. Second, bivariate GCTA-
GREML analysis23 was used on cognitive data from Generation Scotland
and BMI data in American adults from four publicly available data sets. This
approach estimates the genetic correlation through the SNP/phenotypic
similarities in the independent samples. Third, summary GWAS output
from the Davies et al.9 and Locke et al.10 papers were used to estimate the
genetic correlation via the LDSC regression method.24 This method does
not require raw genotype or phenotype information, and nor does it
matter if there is an overlap of individuals in the two GWAS
analyses. Briefly, this approach uses Linkage Disequilibrium (LD) structure
(SNPs in regions of high LD will tag a greater part of the genome than
those in low LD) whereby a SNP’s association with a phenotype will result
from its individual contribution and that of the surrounding SNPs in LD
with it. In a bivariate setting, the expectation of the product of the
statistical scores (z-scores) for the SNP–phenotype associations can be
expressed as an intercept term and another term, including the genetic
covariance between the traits, which does not depend on sample overlap
for the input GWAS data.
A polygenic score for general cognitive function was calculated using
data from a GWAS of general cognitive function (n= 48 462);9 Generation
Scotland did not contribute to the meta-GWAS. The greatest proportion of
variance (1.27%, P= 1.5 × 10− 17) explained in general cognitive function
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was for a predictor that used SNPs with a P-value o0.5 in creating the
score.9 Here we use the same predictor. For a brief summary of polygenic
risk scoring, please see Supplementary Information File S2.
A polygenic score for BMI was created using summary data from a
recent meta-analysis, which included 339 224 individuals.10 Generation
Scotland was not included in the study. The greatest proportion of
phenotypic variance in BMI is explained by a predictor that contains a
subset of all HapMap 3 SNPs.10 We applied this predictor to our data.
Linear regression models were used to assess the relationship between
the phenotypes and the polygenic scores, controlling for age, sex and
population stratification (the first 14 prinicipal components (PCs)). The
polygenic scores were pre-adjusted for age, sex and the 14 PCs with the
residuals being used in the main models.
Using the results from the polygenic prediction analysis, we can provide
estimates for the genetic correlation between cognitive function and BMI,
based on their theoretical relationships (Supplementary Information File S3).
The GWAS output from the general cognitive function and BMI studies
were merged to identify SNPs common to both analyses (Supplementary
Information File S4). Significant hits at a suggestive threshold of
Po5 ´ 10− 5 in both studies were carried forward as potential polygenic
variants that are important for individual differences in both traits. The
total number of hits observed was compared with the expected number,
based on an assumption of the two traits being independent.
Analyses were carried out in R.36 The polygenic risk scores were created
using Plink.37,38
RESULTS
A summary of the Generation Scotland cohort is presented in
Table 1. The cohort had a median (interquartile range) age of 57
(49–63) years. Fifty-nine per cent of the cohort was female and
the median education attained was 12–13 years. The mean BMI of
the cohort was in the overweight range: 27.1 (s.d. 4.9) kg m− 2. The
summary data (means and s.d.) for the four cognitive tests that
were used in the construction of the general cognitive factor are
also presented in Table 1.
The age- and sex-adjusted linear regression model (Table 2)
yielded a standardised effect size (β) of − 0.10 (s.e. 0.01,
P= 1.3 × 10− 14, n= 6273) between the phenotypic measures of
general cognitive function and BMI—better cognitive function is
correlated with lower BMI. There was no evidence for a non-linear
association between cognitive function and BMI after controlling
for age and sex (P= 0.090). A box plot showing the distribution of
cognitive function scores by BMI decile is presented in
Supplementary Information S5.
Estimates of the SNP-based heritabilities are presented in
Table 3. The first approach, using data from the Generation
Scotland sample alone, found univariate estimates, which
represent the proportion of variance in the traits explained by
common genetic variants, of 29% (s.e. 6%) for cognitive function
and 28% (s.e. 6%) for BMI. The estimates for the second approach,
which used data from Generation Scotland for cognitive function
and the four US-based cohorts for BMI, were 31% (s.e. 5%) for
cognitive function and 22% (s.e. 2%) for BMI. The estimates for the
third approach (LD scoring), which used summary GWAS data
from the Davies et al.9 and Locke et al.10 papers, were substantially
lower for both traits: 15% (s.e. 1%) for cognitive function and 14%
(s.e. 1%) for BMI.
Estimates of the genetic correlation between cognitive function
and BMI for the three approaches are also reported in Table 3. The
first method, bivariate GCTA-GREML using data from Generation
Scotland for both traits, yielded a genetic correlation of − 0.51 (s.e.
0.15). The estimate of the same genetic correlation was − 0.10 (s.e.
0.08) using the independent-samples GCTA-GREML (Generation
Scotland data for cognitive function, GENEVA and Health and
Retirement Study data for BMI). The estimate for the third
approach (LDSC regression), which used the summary GWAS data
from Davies et al.9 and Locke et al.10 was − 0.22 (s.e. 0.03). All three
estimates consistently indicate that the genes associated with
better cognitive function are also associated with a lower BMI.
The polygenic predictions, which were built using the GWAS
summary data from the Davies et al.9 and Locke et al.10 GWASs
and applied to the Generation Scotland cohort, are shown in
Table 4. The polygenic score for general cognitive function
predicted general cognitive function, explaining 0.81% of its
variance (P= 3.3 × 10− 13, n= 6273). The polygenic score for
general cognitive function also predicted 0.08% of the variance
Table 1. Characteristics of the unrelated genotyped Generation
Scotland cohort study members
Unrelated genotyped cohort
Variable n Mean
(s.d.) or N (%)
Range
Demographics
Age (years) 6463 57a 49–63 18–98
Sex: female 6463 3783 59
Body mass index (kg m− 2) 6463 27.1 4.9 17–50
Cognitive function
Digit symbol test (0–133) 6379 68.5 16.7 0–133
Verbal fluency (0–inf ) 6392 41.0 12.1 0–97
Logical memory (0–50) 6386 30.3 7.9 0–50
Mill Hill vocabulary scale (0–44) 6353 31.3 4.7 0–44
aMedian (quartiles).
Table 2. General cognitive function associations with BMI
General cognitive function n Betaa s.e. P-value
Unadjusted association 6273 − 0.11 0.01 o2.0 × 10− 16
Adjusted for age and sex 6273 − 0.10 0.01 1.3 × 10− 14
Abbreviation: BMI, body mass index. aThe dependent variable and
continuous independent variables were standardised in the regression
models.
Table 3. Age-, sex- and population stratification-adjusted univariate
and bivariate GCTA-derived and LDSC-derived estimates
Univariate estimates n esta s.e.
General cognitive function
Same-sample GCTA 6273 0.29 0.06
Independent-samples GCTA 6985 0.31 0.05
LDSC 48 462 0.15 0.01
BMI
Same-sample GCTA 6463 0.28 0.06
Independent-samples GCTA 20 806 0.22 0.02
LDSC 339 224 0.14 0.01
Bivariate estimates N rG s.e.
Same-sample GCTA 6273:6463 − 0.51 0.15
Independent-samples GCTA 6985:20 806 − 0.10 0.08
LDSC 48 462:339 224 − 0.22 0.03
Abbreviations: BMI, body mass index; GCTA, genome-wide complex trait
analysis; LDSC, Linkage Disequilibrium Score Regression; rG, genetic
correlation. aThe proportion of variance in the phenotype explained by
common genetic variants.
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in BMI (P= 0.020, n= 6463). The polygenic predictor for BMI
explained 7.1% of the variance in BMI (Po2 × 10− 16, n= 6463),
consistent with that reported previously,10 and 0.42% of the
variance in general cognitive function (P= 1.9 × 10− 7, n= 6273).
An analysis of the overlapping SNP variants from the cognition
and BMI meta-GWASs identified seven variants (from fours genes:
AKAP6, TOMM40, TMEM161B and TNRC6B) that were significant for
both traits at Po5 × 10− 5, which was greater than by chance
(P= 0.007; Supplementary Information File S4).
DISCUSSION
This study found an overlap of genetic influences on two
important correlates of health outcomes over the life course:
BMI and cognitive function. The phenotypic correlation between
the traits was − 0.11, indicating that better cognitive function is
associated with lower BMI. The three estimates of the genetic
correlation ranged between − 0.51 and − 0.10. A genetic correla-
tion quantifies how genetic variants in one trait are correlated
with genetic variants for another trait, averaged over the genome.
Here, the gene variants associated with increased cognitive
function scores were associated with lower BMI. We also showed,
using polygenic risk score predictors derived from independent
studies, that individual common genetic variants associated with
BMI explain a significant proportion of the variance in cognitive
function and vice versa. These proportions (0.42 and 0.08%) are
very small. However, when they are compared with the
proportions of variance that each polygenic risk score explained
in their own respective phenotype (0.81 and 7.1%), this makes the
former appear more substantial. There are seven individual
genetic variants (four independent) that are associated with both
traits at Po5x10− 5, which is significantly more than expected by
chance (P= 0.007). Taken together, these findings point towards
some shared biological underpinnings for BMI and general
cognitive function.
The three empirical approaches taken to calculate the genetic
correlation along with the theoretically derived estimate, based on
the polygenic prediction results, is a strength of the study.
Another strength is the novelty of the hypotheses being tested—
using polygenic scores from BMI to predict general cognitive
function and vice versa. Such analyses are important, as they aid
our understanding of common sets of genetic variants that
associate with multiple outcomes. We explored this further by
examining the overlap of top hits from previous GWAS analyses of
general cognitive function and BMI.
Although the Generation Scotland study had a large sample size,
the same-sample genetic correlation still carried a relatively large
s.e. Compared with the same-sample analysis, the independent-
samples bivariate GCTA-GREML reduced the s.e. of the genetic
correlation from 0.15 to 0.08, which then dropped further to 0.03
when we used the LDSC regression approach. With the decreasing
s.e. came a convergence of the genetic correlation to an estimate
of − 0.22 from the LDSC regression analysis, which was contained
in the 95% confidence intervals for the independent-sample and
just inside of the same-sample GCTA-GREML interval. Again, it is
worth noting that the same-sample GCTA-GREML estimate was
measured with a lack of precision—its 95% confidence interval was
(−0.80, − 0.22). Theoretically, we would expect, given the polygenic
prediction results, to have observed a genetic correlation of around
− 0.32 to − 0.24 (Supplementary Information File S3), which is in
line with the genetic correlation estimated from the LDSC
regression analysis. One limitation of the Generation Scotland
cohort for this study is the cross-sectional nature of the data. It may
be the case that the association between BMI and cognitive
function is diluted when looking in a cohort with a broad
age range.
The univariate GCTA-GREML estimates obtained here are in
accordance with those previously reported for general cognitive
function9 and slightly higher for BMI.18,19 The small within-trait
polygenic prediction estimates correspond to those reported in
the literature for cognitive abilities (~1%).9 The results accord with
one of the predictions of the system integrity hypothesis, whereby
cognitive function is hypothesised to be associated with health
outcomes, because they all reflect a common general build quality
of an organism.39–41 These results are also consistent with the
finding that BMI-related diabetes is equally strongly associated
with lower cognitive function before and after the onset of the
disease.7 Larger meta-analysis GWAS studies for cognitive function
and BMI will improve the predictive power of the polygenic
predictors. Sequencing studies in very large samples that
incorporate rare variants might also help us explain some of the
missing heritability between molecular estimates of heritability
and twin-based findings.
BMI and cognitive function are associated with numerous
health outcomes.1–3,15,42,43 Whereas the phenotypic correlation
between the two traits is small, the genetic correlation is
moderate, suggesting common biological pathways. Another
possible explanation is that the associations reflect causal path-
ways. Techniques such as Mendelian Randomisation may help to
tease apart determine the extent to which the pathways are
shared versus linear (for example, genes to cognitive function, to
BMI).44 The GWAS hits that are significant for both traits are found
in genes linked to insulin-related processes (AKAP6), lipid
transportation and Alzheimer’s disease (TOMM40), retinal arterioral
calibre (TMEM161B) and height (TNRC6B). The TOMM40 SNP also
tags the e4 allele defining SNP of APOE. Given the links between
type 2 diabetes and impaired cognitive function, retinal micro-
vascular disease and cognitive function, and height with cognitive
function (and obviously BMI), these are plausible candidates that
warrant further exploration. It is possible that there is an overlap in
the anatomical substrate in the brain for the expression of the
genes associated with both cognitive function and BMI.10 Future
studies could consider downstream analyses to investigate
whether these markers lie on causal pathways for the determina-
tion for either trait. For example, epigenetic marks such as DNA
methylation have been identified as correlates of BMI in both
blood and adipose tissue,45 as well as correlates of dementia in a
case–control study of diabetics.46
Understanding the genetics of BMI and its overlap with the
genetics of other correlates/predictors of health outcomes, for
example, cognitive function, will help elucidate common path-
ways of disease outcomes. This study identified a small
phenotypic correlation between BMI and cognitive function that
Table 4. Age- and sex-adjusted polygenic risk score associations with
BMI and general cognitive function
n Betaa s.e. P-value
General cognitive function polygenic scoreb
General cognitive
function
6273 0.090 0.01 3.3 × 10− 13
BMI 6463 − 0.029 0.01 0.020
BMI polygenic scoreb
General cognitive
function
6273 − 0.065 0.01 1.9 × 10− 7
BMI 6463 0.266 0.01 o2 ×10− 16
Abbreviation: BMI, body mass index. aThe dependent variable and
continuous independent variables were standardised in the regression
models. bPolygenic risk scores were adjusted for age, sex and 14 multi-
dimensional scaling components with residuals taken forward as the
independent variable of interest.
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is roughly half the size of the genetic correlation. Although
genetic prediction of these traits is very small when applied to an
individual, when coupled with the overlapping SNP hits for the
traits they highlight shared genetic pathways for two important
predictors of health outcomes, BMI and cognitive function.
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